Giannoula Klement - Concepedia

Author

Giannoula Klement

Also Known As

G Klement, G L Klement, G. Klement, G. L. Klement, G.L. KLEMENT, G.L. Klement, GIANNOULA KLEMENT, Giannoula Klement, Giannoula L. Klement, Giannoula Lakka Klement

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Boston Children's Hospital Harvard University Tufts Children's Hospital Brigham and Women's Hospital

About

Giannoula Klement is an author at Dana-Farber Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2.1K
2	Health Sciences	4	4	342
3	Engineering	2	2	68
4	Public Health	1	1	25
5	Anesthesia	1	1	25

Giannoula Klement

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity Giannoula Klement, Sylvain Baruchel, Janusz Rak, Journal of Clinical Investigation	2000	1.2K
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released Joseph E. Italiano, Jennifer L. Richardson, Sunita Patel–Hett, Blood	2007	835
Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry Emily Christison‐Lagay, Patricia E. Burrows, Ahmad I. Alomari, Journal of Pediatric Surgery HepatologyHepatic HemangiomasHepatobiliary TumorSurgical PathologyHistopathology	2007	374
Platelets actively sequester angiogenesis regulators Giannoula Klement, Tai‐Tung Yip, Flávia Cassiola, Blood	2008	339
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles Robert Flaumenhaft, James R. Dilks, Jennifer L. Richardson, Blood	2008	313
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Giannoula Klement, Ping Huang, Barbara Mayer, PubMed Breast OncologyPathologyPharmacotherapyMetronomic ChemotherapyTumor Mass	2002	246
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients Jon E. Peterson, David Zurakowski, Joseph E. Italiano, Angiogenesis ThrombopoiesisBlood PlateletMedicineHematologyPathology	2012	233
A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer Mark W. Kieran, Christopher Turner, Joshua B. Rubin, Journal of Pediatric Hematology/Oncology Surrogate MarkersPathologyPharmacotherapyMetronomic ChemotherapyCancer Chemotherapy	2005	202
Normal ranges of angiogenesis regulatory proteins in human platelets Jon E. Peterson, David Zurakowski, Joseph E. Italiano, American Journal of Hematology Healthy SubjectsImmunologyPathologyTumor BiologyThrombosis	2010	159
Cell Therapy, a New Standard in Management of Chronic Critical Limb Ischemia and Foot Ulcer Václav Procházka, Jaromír Gumulec, František Jalůvka, Cell Transplantation	2010	146

Page 1